Cancers | Free Full-Text | Atypical BRAF and NRAS Mutations in Mucosal Melanoma
BRAF vs RAS oncogenes: Are mutations of the same pathway equal? Differential signalling and therapeutic implications | Oncotarget
Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations | Scientific Reports
Genes | Free Full-Text | Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks
Význam testování RAS u kolorektálního karcinomu
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
Veterinary Sciences | Free Full-Text | Comparative Aspects of BRAF Mutations in Canine Cancers
Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF Variants - ScienceDirect
BRAF Mutation in Colorectal Cancer Anita Turk, MD; Dustin Deming, MDDivision of Hematology and Oncology,Department of MedicineUniversity of Wisconsin-Madison School of Medicine and Public Health and University of Wisconsin Carbone Cancer Center,
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Cancers | Free Full-Text | BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge
Cancers | Free Full-Text | Targeting BRAF and RAS in Colorectal Cancer
BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells by Reactivating MEK and ERK Signaling | Science Signaling
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
Mutant KRAS can induce either BRAF/BRAF or BRAF-CRAF dimerazaiton of... | Download Scientific Diagram
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF: Cell
IJMS | Free Full-Text | The Role of BRAF in Metastatic Colorectal Carcinoma–Past, Present, and Future
Frontiers | Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM
Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia | Leukemia
Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy - Decaussin‐Petrucci - 2017 - Cytopathology - Wiley Online Library
Decision algorithm used in our laboratory for the determination of... | Download Scientific Diagram
